Article
Molecular study of proteinuria in patients treated with B₁₂ supplements: do not forget megaloblastic anemia type 1.
Nephron. Clinical practice - 1 Jan 2011
Levin-Iaina Nomy, Dinour Dganit, Morduchowicz Gabriel, Ganon Liat, Holtzman Eli J
Abstract excerpt
BACKGROUND/AIMS: Current consensus supports the notion that proteinuria is a marker of renal disease with prognostic implications. Whereas most chronic kidney disease patients with proteinuria would often require antiproteinuric agents, there are some exceptions. Megaloblastic anemia type 1 (MGA1) is characterized by megaloblastic anemia due to congenital selective vitamin B(12) malabsorption and proteinuria. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
